Mounting evidence clearly shows both the paramount importance of the PI3K pathway in the tumorigenesis of many human malignancies including HNSCC, and the promising results of targeting this pathway for treatment of human cancer patients. This evidence concerns the gene PIK3CD and head and neck squamous cell carcinoma.